Raid Aljumaily, MD, assistant professor, Hematology/Oncology, joined the Stephenson Cancer Center in 2014. His interest in thoracic oncology started during his fellowship years at Tufts Medical Center in Boston, where he learned a broad spectrum of methods and approaches to treating thoracic malignancies. Aljumaily continues to build upon this knowledge through utmost patient care and extensive research, particularly, a phase II study of low-dose paclitaxel with timed thoracic radiotherapy followed by adjuvant chemotherapy.
While in East Carolina University, he did a retrospective review of his experience treating lung cancer patients with oligometastatic disease. Dr. Aljumaily’s background inspires him to link basic science findings to clinical research ideas for patients with lung cancer.
Fellowship: Tufts Medical Center
Residency: Drexel University College of Medicine
Medical School: Baghdad University, College of Medicine
Retrospective review of past experience in treating patients with non-small cell lung cancer with oligometastatic disease with curative intent
Phase II study to treat patients with minimal stage VI non-small cell lung cancer with curative intent
Honors and Awards:
National Institute of Health, National Cancer Institute, T32 Research Training Grant, 2009-11
Oral presentation at the ECOG Young Investigator Symposium, 2010
American Board of Hematology
American Board of Medical Oncology
American Board of Internal Medicine
Medical Licensing Examination (USMLE)